Real-time enrollment status for this transthyretin amyloidosis clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 12:41 PM UTC
| NCT Number | NCT06465810 |
| Recruiting Status | Recruiting |
| Condition | Transthyretin Amyloidosis |
| Phase | Clinical Trial |
| Target Enrollment | 1,850 participants |
| Active Locations | 33 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | August 19, 2026 (1 week ago) |
As of August 27, 2026: Clinical trial NCT06465810 is currently recruiting participants. This clinical trial study for transthyretin amyloidosis is actively seeking new participants at 33 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06465810 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 33 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06465810 was last updated 1 week ago (August 19, 2026). HelloStudys verifies this status automatically.